Clinical Trial Update: A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study [Phase 3]

View source ↗

Summary

A Phase 3 follow-up extension study assessing persistence of immune response to GSK's HPV vaccine in healthy Chinese females who completed three doses previousl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cervical Intraepithelial Neoplasia | Phase 3 | Status: COMPLETED | Results posted: 2019-06-10